None listed
Conditions
Interventions
Dietary Supplement : Consumption of Lactobacillus gasseri BNR17 for 12 weeks (10^9 CFU/day or 10^10 CFU/day)
Sponsors
Bioneer
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Voluntarily agree to participate and sign in informed consent form 2) Age: 20-65 years 3) BMI: 25kg/m2 = ~ = 35kg/m2
Exclusion criteria
Exclusion criteria: 1) Subject who takes antiobesity drugs that affect body weight. 2) Subject who consumes probiotics within 2 weeks before the first visit. 3) Subject who cannot follow the dietary instruction during the study. 4) Subject who has following diseases:hypertension (=160/100mmHg), diabetes, hepatic dysfunction, renal dysfunction, hyperthyroidism or hypothyroidism, Cushing's syndrome, malignant tumors. 6) Subject who has an allergy to the ingredients of study product. 7) Subject who participated in another clinical trials within 4 weeks before the first visit. 8) Subject who is pregnant or bresat feeding. 9) Any condition that would make the subject unsuitable for enrollment in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CT (Abdominal fat area: total fat area, visceral fat areat, subcutaneous fat area) | — |
Secondary
| Measure | Time frame |
|---|---|
| DEXA (body fat mass, lean body mass, %body fat) ;Anthropometric measurements (body weight, BMI, waist circumference, hip circumference);Blood lipid profiles;Biomarkers of blood glucose;Blood inflammatory biomarkers | — |
Countries
Korea, Republic of
Contacts
Public ContactJae Moon Yun
Seoul National University Hospital
Outcome results
None listed